title: [Total androgen blockade: an argument in favor].
authors.forename: F
authors.initials: F
authors.lastname: Labrie
authors.forename: Y
authors.initials: Y
authors.lastname: Lacourcière
authors.forename: A
authors.initials: A
authors.lastname: Bélanger
authors.forename: G
authors.initials: G
authors.lastname: Monfette
authors.forename: N
authors.initials: N
authors.lastname: Bergeron
authors.forename: A
authors.initials: A
authors.lastname: Dupont
authors.forename: S
authors.initials: S
authors.lastname: Pinault
authors.forename: J
authors.initials: J
authors.lastname: Emond
authors.forename: G
authors.initials: G
authors.lastname: Manhès
authors.forename: L
authors.initials: L
authors.lastname: Cusan
mesh_terms: D000726:Androgen Antagonists / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D011471:Prostatic Neoplasms / Q000188:drug therapy*
chemical_list: D000726:Androgen Antagonists
vernacular_title: Le blocage androgénique total: du pour.